CVM
CEL SCI CORP
Key Financials
Revenue
$264033
↑ 289.3%
Operating Income
$-24809736
↑ 5.9%
Net Income
$-25411055
↑ 7.9%
Total Assets
$28.2M
↑ 4.3%
Shareholders' Equity
$16.0M
↑ 24.0%
EPS (Diluted)
$-6.27
↓ 1129.4%
Cash & Equivalents
$22.7M
↓ 37.1%
Total Liabilities
$12.2M
↓ 13.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| RW | 5/19/2026 | View on SEC |
| 4 | 5/18/2026 | View on SEC |
| 10-Q | 5/15/2026 | View on SEC |
| 8-K | 5/14/2026 | View on SEC |
| 4 | 5/14/2026 | View on SEC |
| 8-K | 5/13/2026 | View on SEC |
| 424B4 | 5/13/2026 | View on SEC |
| EFFECT | 5/11/2026 | View on SEC |
| S-1/A | 5/1/2026 | View on SEC |
| DEL AM | 4/24/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CVM |
| Company Name | CEL SCI CORP |
| CIK | 725363 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | NYSE |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 0930 |
| State of Incorporation | CO |
| Phone | 7035069460 |